Clinicians should, therefore, monitor linear growth closely in children with ARPKD and other causes of congenital CKD and should utilize strategies to improve growth, including ensuring adequate enteral nutrition and normal acid–base status and prescribing growth hormone as indicated. Here, GH1 is linked to chronic kidney disease.